Literature DB >> 27873226

Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?

Brendan Mulhern1, Richard Norman2, Paula Lorgelly3, Emily Lancsar4, Julie Ratcliffe5, John Brazier6, Rosalie Viney7.   

Abstract

BACKGROUND: Discrete choice experiments with duration (DCETTO) can be used to estimate utility values for preference-based measures, such as the EQ-5D-5L. For self-completion, the health dimensions are presented in a standard order. However, for valuation, this may result in order effects. Thus, it is important to understand whether health state dimension ordering affects values. The aim of this study was to examine the importance of dimension ordering on DCE values using EQ-5D-5L.
METHODS: A choice experiment presenting two health profiles and a third immediate death option was developed. A three-arm study was used, with the same 120 choice sets presented online across each arm (n = 360 per arm). Arm 1 presented the standard EQ-5D-5L dimension order, arm 2 randomised order between respondents, and arm 3 randomised within respondents. Conditional logit regression was used to assess model consistency, and scale parameter testing was used to assess model poolability.
RESULTS: There were minor inconsistencies across each arm, but the magnitudes of the coefficients produced were generally consistent. Arm 3 produced the largest range of utility values (1 to -0.980). Scale parameter testing suggested that the models did not differ, and the data could be pooled. Follow-up questions did not suggest variation in terms of difficulty.
CONCLUSIONS: The results suggest that the level of randomisation used in DCE health state valuation studies does not significantly impact values, and dimension order may not be as important as other study design issues. The results support past valuation studies that use the standard order of dimensions.

Entities:  

Mesh:

Year:  2017        PMID: 27873226     DOI: 10.1007/s40273-016-0475-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  19 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  The estimation of a preference-based measure of health from the SF-12.

Authors:  John E Brazier; Jennifer Roberts
Journal:  Med Care       Date:  2004-09       Impact factor: 2.983

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.

Authors:  Mark Oppe; Nancy J Devlin; Ben van Hout; Paul F M Krabbe; Frank de Charro
Journal:  Value Health       Date:  2014-06       Impact factor: 5.725

5.  Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

Authors:  Brendan Mulhern; Nick Bansback; John Brazier; Ken Buckingham; John Cairns; Nancy Devlin; Paul Dolan; Arne Risa Hole; Georgios Kavetsos; Louise Longworth; Donna Rowen; Aki Tsuchiya
Journal:  Health Technol Assess       Date:  2014-02       Impact factor: 4.014

6.  Do health preferences contradict ordering of EQ-5D labels?

Authors:  Benjamin M Craig; A Simon Pickard; Kim Rand-Hendriksen
Journal:  Qual Life Res       Date:  2014-12-18       Impact factor: 4.147

7.  The Impact of Different DCE-Based Approaches When Anchoring Utility Scores.

Authors:  Richard Norman; Brendan Mulhern; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

8.  A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

9.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

10.  Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues.

Authors:  Nick Bansback; Arne Risa Hole; Brendan Mulhern; Aki Tsuchiya
Journal:  Soc Sci Med       Date:  2014-05-20       Impact factor: 4.634

View more
  3 in total

1.  Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.

Authors:  Madeleine T King; Rosalie Viney; A Simon Pickard; Donna Rowen; Neil K Aaronson; John E Brazier; David Cella; Daniel S J Costa; Peter M Fayers; Georg Kemmler; Helen McTaggart-Cowen; Rebecca Mercieca-Bebber; Stuart Peacock; Deborah J Street; Tracey A Young; Richard Norman
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981

2.  Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments.

Authors:  Marcel F Jonker; Bas Donkers; Esther de Bekker-Grob; Elly A Stolk
Journal:  Health Econ       Date:  2018-12-18       Impact factor: 3.046

3.  Discrete Choice Experiments in Health Economics: Past, Present and Future.

Authors:  Vikas Soekhai; Esther W de Bekker-Grob; Alan R Ellis; Caroline M Vass
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.